Navigation Links
AIDS Drugs Don't Need Routine Lab Monitoring
Date:12/9/2009

Finding is good news for first-line treatment in Africa, researchers say

WEDNESDAY, Dec. 9 (HealthDay News) -- In a finding that has implications for how the AIDS virus is treated in Africa, new research suggests that antiretroviral drugs can be given without routine monitoring by lab tests.

But tests of immune-system function might still be a good idea to monitor the progression of the disease and guide the second year of treatment, the study authors report.

Patients with HIV, the virus that causes AIDS, often receive drug treatment in Africa without routine laboratory monitoring. In the study, published online Tuesday in advance of publication in a future print issue of The Lancet, researchers tried to determine if that's a bad idea.

They studied 3,316 HIV-positive adults who were assigned to monitoring in both the doctor's office and the laboratory or only in the doctor's office. The patients were studied in Uganda and Zimbabwe.

"The results clearly show that first-line [antiretroviral therapy, or ART] can be delivered safely without routine biochemistry and hematology monitoring for toxic effects, but that routine CD4-cell count monitoring has a small but significant benefit in terms of disease progression and mortality, probably owing to slightly earlier switching to second-line ART," the researchers wrote.

More information

Avert has more about AIDS in Africa.



-- Randy Dotinga



SOURCE: The Lancet, news release, Dec. 9, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved

Page: 1

Related medicine news :

1. Statement of HDMA President and CEO John M. Gray on the Importation of Prescription Drugs
2. Case Western Reserve to receive $19.7m to study tuberculosis treatment drugs
3. OrderOnlineDrugs.com Makes Ordering Drugs Online Safe and Affordable
4. Second-line CML drugs evoke faster response than front-line therapy
5. Hormonal Drugs Cool Hot Flashes From Prostate Cancer Therapy
6. Cholesterol-lowering drugs also may protect stem cell transplant patients from GVHD
7. Diabetes Drugs Go Head-to-Head in Study
8. drugstore.com Continues Global Sales Expansion to More Than 3.5 Billion International Consumers
9. China Nepstar Chain Drugstore Reports 92.1% Year-on-Year Increase in Operating Income for Third Quarter 2009
10. Coverage of inexpensive drugs may increase length and quality of life after heart attack
11. Gene increases effectiveness of drugs used to fight cancer and allows reduction in dosage
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer care, and ... in the eye of the beholder, according to experts who offered insights and commentary ... of Managed Care. For the full issue, click here . , For the ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are ... with endometriosis. These women need a treatment plan to not only alleviate symptoms ... can help for preservation of fertility and ultimately achieving a pregnancy. The specialists ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the largest ... as the Medical Director of its new Mesquite-Samuell Farm facility. , “We are ... Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that ... chosen by their peers for this recognition are considered among the top 2 percent ... special honors as members of this year’s Legal Elite Hall of Fame: Miami ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Dialysis Devices Global Market - Forecast to 2022" report ... is the treatment method for the patients with kidney failure, ... and excess fluid from the patient,s blood and thus the ... sodium, potassium and chloride in balance. Increasing ...
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
Breaking Medicine Technology: